← FDA Drug Approvals (Drugs@FDA)

DIAZEPAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2026-07-28

Drug application

FDA Application #

ANDA219882

Application type

Abbreviated New Drug Application (Generic)

Brand name

DIAZEPAM

Generic name

DIAZEPAM

Active ingredients

DIAZEPAM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2026-07-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown